New industrial orders in Germany increased month on month in December 2021
Data released by the German Federal Bureau of statistics on the 4th showed that driven by the growth of new domestic orders in Germany, new industrial orders in Germany increased by 2.8% month on month in December 2021, the second consecutive month on month growth after adjusting for seasons and working days. The data show that in December 2021, new orders in Germany increased by 11.7% month on month, and new orders abroad decreased by 3.0% month on month; New orders from the eurozone decreased by 4.2% month on month, and new orders from outside the eurozone decreased by 2.3% month on month.
This text is a result of machine translation.
Related companies：
Briefing Jun 20, 2022 04:54 PM
· Technology
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
In-depth
Healthcare
Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying
The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?
Feb 21, 2022 02:30 PM
Apr 28, 2022 08:00 PM
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Dec 19, 2020 07:42 AM
Healthcare
Biotech Firm ImmuneOnco Submitted Listing Application on the Main Board of HKEX
ImmuneOnco, focusing on developing new-generation tumor immunotherapeutic, will further accelerate the development of other promising drug candidates targeting checkpoints of innate and adaptive immunity.
Yesterday 10:58 PM
In-depth
In-depth
Healthcare
BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Jun 24, 2022 12:13 PM
Briefing Jan 21, 2022 12:19 PM
· Technology
Changchun hi tech: nine directors, supervisors and senior management personnel increased their holdings of 84700 shares in the company
Briefing Jan 20, 2022 02:49 PM
· Technology
Consumer electronics stocks continued to decline
See more
Read next
In-depth
In-depth
Technology
A Closer Look at China’s Cloud Service Market, Guessing Who Will Succeed? [1/2]
Jun 27, 2022 05:09 PM
In-depth
Healthcare
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Jun 27, 2022 12:24 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.